Pakistan

in page functions
[French]
Total population (2014) 185,132,926
Birth cohort (2014) 4,597,428
Surviving Infants (surviving to 1 year per year, 2014) 4,306,974
Infant mortality rate (deaths < 1 year per 1000 births, 2012) 69/1000
Child mortality rate (deaths < 5 years per 1000 births, 2012) 86/1000
World Bank Index, IDA (2012) 3.08
Gross Nation Income (per capita US$, 2012) 1,260
Co-financing status (2013) Intermediate
No. of districts/territories (2013) 147

Gavi support for Pakistan

Type of support

Approvals

2001-2020 (US$)
(30 Jun 2014)

Commitments

2001-2020 (US$)
(30 Jun 2014)

Disbursements

2000-2014 (US$)
(30 Jun 2014)

% Disbursed

(30 Jun 2014)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Civil Society Organisation support (CSO) $7,656,073 $7,656,073 $7,756,073 101%
Health system strengthening (HSS 1) $23,525,000 $23,525,000 $23,524,500 100%
HepB mono (NVS) $24,953,324 $24,953,324 $24,953,324 100%
Immunisation services support (ISS) $48,763,740 $48,763,740 $43,581,500 89%
Injection safety support (INS) $7,405,082 $7,405,082 $7,405,082 100%
Measles SIA (NVS) $10,397,857 $10,397,857 $10,397,857 100%
Measles SIA - Operational costs (OPC) $21,664,500 $21,664,500 $21,664,500 100%
Penta (NVS) $284,020,409 $314,104,409 $277,604,968 98%
Pneumo (NVS) $226,769,406 $323,613,906 $238,004,209 105%
Tetra DTP-HepB (NVS) $31,387,734 $31,387,734 $31,387,734 100%
Vaccine Introduction Grant (VIG) $6,750,500 $6,750,500 $6,750,500 100%
Total $693,293,625 $820,222,125 $693,030,247

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Pakistan DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2013)

Grade of confidence
72%

N/A
DTP3 - Official country estimates (2012) 89%
M:F sex ratio at birth (2014) 1.09
Household survey: DTP3 coverage for male (2013) 67.20%
Household survey: DTP3 coverage for female (2013) 63.10%
Household survey: Last DTP3 survey (2013) 65%
% districts achieving > 80% DTP3 coverage (2013) 74%
% districts achieving < 50% DTP3 coverage (2013) 10%
MCV WHO/UNICEF estimates (2013) 61%
Polio WHO/UNICEF estimates (2013) 72%

Breakdown of support

Non-vaccine support Vaccine support
16% 84%
$110,682,154 $582,348,089

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Pakistan

20 May 2014

Reasons to invest

Reasons to invest in the GAVI Alliance

From singers and Presidents to Ministers and advocates, GAVI Alliance supporters explain why they are backing the Alliance’s vision for 2020

28 February 2014

Poliomyelitis vaccination and immunization, Ethiopia

GAVI Alliance complements global polio eradication effort

Countries eligible for GAVI Alliance support invited to apply for funding for inactivated polio vaccine until 2015.

07 December 2013

PCV launch Afghanistan 1

Pneumococcal vaccine to protect more than a million children in Afghanistan from leading child killer

Pneumonia accounts for 25% of deaths of children under five in Afghanistan each year.

close icon

modal window here